Is It MDD Or Bipolar Disorder?

Mauricio Tohen, MD, DrPH, MBA, is the Professor and Chairman of the Department of Psychiatry & Behavioral Sciences at The University of New Mexico Health Sciences Center Department of Psychiatry in Albuquerque, NM. His career spans a clinical directorship at the Bipolar and Psychotic Disorders Program at McLean Hospital; Head of the Division of Mood & Anxiety Disorders and the Krus Endowed Tenured Professor in Psychiatry at the University of Texas Health Science Center at San Antonio; and authorship of 250 original publications and co-editor of four books on mood disorders. Dr. Tohen has received numerous awards including the National Service Award in Psychiatric Epidemiology from the National Institute of Mental Health (NIMH) and Harvard University.

Dr. Tohen earned his medical degree from the National University of Mexico and his Doctorate in Public Health (Epidemiology) from Harvard University. His postdoctoral training included a residency in Psychiatry at the University of Toronto and a fellowship at McLean Hospital, Harvard Medical School. Dr. Tohen also obtained an MBA degree from the Indiana University Kelly School of Business.

Madhukar H. Trivedi, MD, is currently a Professor and Chief of the Division of Mood Disorders in the Department of Psychiatry at the University of Texas Southwestern Medical Center at Dallas. He holds the Betty Jo Hay Distinguished Chair in Mental Health. Dr. Trivedi has been a principal investigator in multiple clinical trials for the treatment of depression, focusing on pharmacological, psychosocial, and other nonpharmacological treatments. He was awarded the 2015 American Psychiatric Association Award for Research, the Association’s most significant award for research.

Dr. Trivedi completed his medical studies at Baroda Medical College in Baroda, India, and he completed his residency in Psychiatry at University General Hospital Medical College in Baroda, India, and Henry Ford Hospital in Detroit, Michigan. Dr. Trivedi is board certified by the American Board of Psychiatry and Neurology.

Jessie Chambers, PhD, serves as a Senior Medical Science Liaison for Otsuka Pharmaceutical Development & Commercialization, Inc. Her clinical area of expertise is behavioral health halfway-house/assisted living services, and her research background includes post-mortem schizophrenia, neurocognition in schizophrenia, and white matter alternations in schizophrenia.

Jessie attended the University of Oregon in Eugene, OR, and the University of New Mexico School of Medicine in Albuquerque, New Mexico.